BIOSIM Act
Latest action · Apr 23, 2021 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 22, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act
This bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified.
Cosponsors 4
Members who signed on, in the order they did. Signatures ran from Apr 22, 2021 to Jul 22, 2021; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-IL | Adam Kinzinger | Original | Apr 22, 2021 |
| D-NC | G. K. Butterfield | Jun 29, 2021 | |
| D-NJ | Mikie Sherrill | Jun 29, 2021 | |
| D-WA | Kim Schrier | Jul 22, 2021 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 22, 2021 |
| Health Subcommittee | Referred Apr 23, 2021 | |
| House | Ways and Means Committee | Referred Apr 22, 2021 |
| Health Subcommittee | Referred Apr 22, 2021 | |
| Social Security Subcommittee | Referred Apr 22, 2021 |
Actions 5
Everything that happened, newest first.
- Apr 23, 2021Referred to the Subcommittee on Health.
- Apr 22, 2021Introduced in House
- Apr 22, 2021Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Apr 22, 2021Referred to the Subcommittee on Health.
- Apr 22, 2021Referred to the Subcommittee on Social Security.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 70, April 22, 2021, page H2109.
Printed hearings 2
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 117-809 | PRESCRIPTION DRUG PRICE INFLATION: AN URGENT NEED TO LOWER DRUG PRICES IN MEDICARE224 pages | Finance Committee | Mar 16, 2022 |
| Serial No. 117-27 | NEGOTIATING A BETTER DEAL: LEGISLATION TO LOWER THE COST OF PRESCRIPTION DRUGS139 pages | Energy and Commerce Committee | May 4, 2021 |
Related bills 3
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 4455 | BIOSIM Act | Reintroduction of | Sep 23, 2019 |
| HR 5376 | An act to provide for reconciliation pursuant to title II of S. Con. Res. 14. | Related bill | Aug 16, 2022 |
| HR 7497 | Make Medicine Affordable Act | Related bill | Apr 12, 2022 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XVIII of the Social Security Act to provide for a temporary payment increase under the Medicare program for certain biosimilar biological products to encourage the development and use of such products.
- Short Title(s) as Introduced
- BIOSIM Act
- Bolstering Innovative Options to Save Immediately on Medicines Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Apr 22, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.